Description
Gastrin I, also known as gastrin, or gastric mucosal regenin, is an endogenous peptide produced in the stomach that can act as a selective agonist of cholecystokinin 2 (CCK2) receptors, as well as stimulate gastric acid secretion, and can be used in applications such as culturing gastrointestinal organoids.
Features
Purity≥95%
Standardized production, using factory mass production mode
Specifications
|
Cat.No. |
53007ES03/53007ES08 |
|
Size |
1 mg/5 mg (5×1 mg) |
|
Synonym |
Gastrin I Human |
|
Target |
CCK2 receptor |
|
CAS No. |
10047-33-3 |
|
Molecular formula |
C97H124N20O31S |
|
Molecular weight |
2098.22 |
|
Appearance |
solid powder |
|
Purity |
≥95% |
|
Solubility |
dissolved in 1% ammonia water: 1 mg/mL, need to be sonicated |
|
Sequence |
Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
|
Structure |
|
Components
|
Components No. |
Name |
53007ES03 |
53007ES08 |
|
53007 |
GASTRIN I (HUMAN) |
1 mg |
5 mg (5×1 mg) |
Shipping and Storage
The Gastrin I (human) products should be stored at -15～-25℃ for 2 years. Avoid repeated freeze-thaw cycles.
Documents:
Safety Data Sheet
Manuals
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.